20th Pharmacovigilance 2019

20th Pharmacovigilance 2019 is organized by Virtue Insight and will be held on Nov 07, 2019 at Kohinoor Continental, Mumbai, Maharashtra, India.

Description:
Present review described Pharmacovigilance and drug safety in India. Challenges related to Pharmacovigilance programme, roles of physicians/health professionals as well as role of public/patients for successful monitoring are discussed herewith as nowadays, in India a safety of medicines is one of the key parameters along with therapeutic efficacy for success of any drug as ever-increasing range and potency of medicines.

A successful Pharmacovigilance programme related to drug safety should be able to answer the key questions. How quickly has the case been identified? As well as what proportion of patient has successfully monitored collectively by doctor, Pharmacist/health professionals. As early detection is the key in reducing adverse events to minimum level or at lateral stage it may be a fatal or challenge to the health professionals. Challenges related to Pharmacovigilance programme in India can be avoided by strictly implementing proper rule and regulation everywhere.

Strengthening of public campaigns for drug safety to improve awareness, addition of drug safety study to the curriculum, minimising the level of adverse effects by having sound knowledge about the side effect of the drug as day by day increasing number of medicines may help in monitoring the Pharmacovigilance programme. Interestingly, Improvement of communication regarding Pharmacovigilance between public and health professionals creates awareness so as to minimize adverse occurring. Proper knowledge on Pharmacovigilance would help to health professionals to understand the effectiveness or risk of medicines that they prescribe and ensure a better healthcare to patient.

Virtue Insight’s 20th Pharmacovigilance 2019 Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting. The content of this event is developed by top experts from the biopharmaceutical industry and global regulatory agencies, and Virtue Insight will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.

Key Themes Discussed:
• Pharmacovigilance and social media: An industry view
• Addressing a number of technical, regulatory and ethical challenges
• Traditional medicines and herbal of pharmacovigilance: Solutions and innovations
• Herbal medicines uses: Developing reliable information on safety
• Discussing on the global pharmacovigilance system for India
• Recent development of pharmacovigilance system in India
• Insure safe use of medicines and minimizing the risks related to the medicinal product
• Data generated during clinical trials to provide information about the common adverse events
• Pharmacovigilance: Guidance of biologics and biosimilars
• Monitoring the safety of biologics and biosimilars
• Pharmacovigilance Analytics: The hype of big data for pharmacovigilance
• Establishing the age of big data in pharmacovigilance
• Real-world example of the development of a successful risk management plan
• How to write a successful risk management plan
• The current regulatory framework and its global impact
• Implications for the global environment
• Understanding the global regulatory developments and updates
• New regulatory policy, development, and review
• Be part of a major networking opportunity

Who Should Attend:
• Vice Presidents, Directors, CRO’s, Heads and Managers of:
• Pharmacovigilance Strategy
• Drug Safety/Risk Management
• Information and Clinical Data Management
• Clinical Research
• Research & Development
• Product Safety/Assurance Assessment
• Patient Safety & Outcomes Research & Data Analysis
• Epidemiology project management
• Regulatory Affairs and Compliance
• Sales & Marketing
• Biotech manufacturers

From the following:
• Pharmaceutical organizations
• Generic pharmaceutical companies
• Contract research organizations
• Patient recruitment companies
• Government- Department of health
• Non-profit organizations/ Association
Consultants

Additional details will be posted as soon as they are available.